To investigate the effect in vivo, a mixture of tumor cells and NEPs were injected intrathoracically into the lungs followed by injection of monoclonal antibodies S100a4 or sRAGE, which decreased the metastatic burden (Fig. 5e,f) and the size of the metastatic nodules (Fig. 5g). Here, S100A4 is linked to neoplasm.